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Background: Neonatal sepsis is the most serious problem in neonatal intensive care, 
resulting in significant morbidity and mortality. We evaluated the causative pathogen, 
drug sensitivity, hematological parameters, clinical course and mortality rate of 
neonatal sepsis in a Taiwanese medical center and compared our results to those of 
previous studies conducted in Taiwan. 
Methods: Neonates admitted to the neonatal intensive care unit (NICU) at National 
Taiwan University Hospital (NTUH) between January 2001 and December 2006 were 
included in this study. Patients were divided into early-onset sepsis and late-onset 
sepsis groups if their culture tested positive within the first 7 days of life or later, 
respectively.
Results: A total of 109 episodes of sepsis were identified in 100 neonates. The inci-
dence of sepsis was 4.06% among all NICU admissions. Most neonates with early-onset 
sepsis were term infants, while very low birth weight (VLBW) and preterm infants 
accounted for the majority of cases of late-onset sepsis. In early-onset sepsis, the 
most common pathogens responsible included group B streptococci (GBS) (36%) and 
Escherichia coli (E. coli) (26%). GBS was associated with more meningitis involvement 
but lower incidence of mortality compared with E. coli. The most common causative 
micro organisms in late-onset sepsis were coagulase-negative staphylococci (CONS) 
(40%) and Candida (15%). The sepsis-related mortality rates were higher in early-onset 
sepsis (10%) than in late-onset sepsis (7%).
Conclusion: Unlike previous reports from Taiwan, in the present study, GBS was found 
to be the leading pathogen in early-onset sepsis. GBS screening and intrapartum anti-
biotic prophylaxis guidelines should be used in Taiwan to prevent early neonatal sepsis. 
The most common causative microorganisms of late-onset sepsis were CONS and 
Candida species. Candida parapsilosis was associated with a high mortality rate.
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Neonatal sepsis remains the most serious problem 
in neonatal intensive care and results in significant 
morbidity and mortality, particularly in very low 
birth weight (VLBW) preterm infants. Because tem-
poral and geographic differences in pathogens as-
sociated with neonatal sepsis have been observed, 
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it is important to recognize the common pathogens 
and associated drug sensitivities for individual hos-
pitals. Empiric antibiotic therapy will be ineffective 
if the decision is not made according to the ordinary 
causative microorganism in each specific, neonatal 
intensive care unit (NICU). 
Here, we evaluated the causative pathogen, in-
cidence, clinical course and mortality rate of neona-
tal sepsis over a 6-year period in a Taiwanese medical 
center. We compared our findings with those of previ-
ous studies conducted in Taiwan.
2.  Materials and Methods
Infants admitted to the NICU at the National Taiwan 
University Hospital (NTUH) between January 2001 
and December 2006 were included in this study. 
Patients’ chart records were retrospectively reviewed 
for gestational age, birthweight, pathogen, symptoms 
and signs, age at onset of sepsis, time between cen-
tral line insertion and removal days, dura tion of ven-
tilator use, hematocrit, C-reactive protein (CRP) 
and mortality. NTUH is a teaching hospital that pro-
vides tertiary care in the northern part of Taiwan. 
It has a level three NICU with a total of 24 beds. 
Each NICU nurse cares for two or three babies. There 
are four attending neonatologists, four neonatal fel-
lows, four pediatric residents and two intern doctors 
working in the NICU.
Approximately 0.5−1 mL of blood was drawn in 
sterile conditions after peripheral puncture. The anti-
microbial hand washing solutions used are Hibiscrub 
and Better-Iodine. Visitors are restricted to two per 
bed at one time and are required to wash their hands 
and wear cover gowns. Prophylactic antifungal treat-
ment is not used in this NICU. Proportions were com-
pared by χ2 test. Relative risks were estimated to 
examine the association between birth weight and 
rate of late-onset sepsis.
2.1.  Definitions
Sepsis was defined by a positive blood and/or ce-
rebrospinal fluid (CSF) culture and unstable vital 
signs. Patients were divided into those with sepsis 
that developed within the first 7 days of life (early-
onset sepsis) and those with sepsis that developed 
after 7 days of life (late-onset sepsis).1 A few infants 
had more than one episode of sepsis. If the organism 
was cultured after 10 days of appropriate antibiotic 
therapy or a different organism was cultured from a 
subsequent culture, this was considered an addi-
tional episode.2 Deaths were attributed to sepsis if 
they occurred within 7 days of a positive culture.3,4 
Catheter-related sepsis was defined as both a pos-
itive blood culture and a positive intravascular 
catheter tip culture involving the same microorgan-
ism without another infection source.1 Nosocomial 
infection was defined as sepsis occurring 48 hours 
after admission.
Cases with positive cultures for coagulase-
negative staphylococci (CONS) were classified as def-
inite infection, possible infection or contamination.2,5 
Definite infection was defined by two positive cul-
tures of blood specimens drawn within 2 days or 
one positive culture with a blood CRP level greater 
than 1 mg/dL within 2 days after blood culture. 
Possible infection was defined by one positive cul-
ture and treatment for at least 5 days with an anti-
staphylococcal agent or another drug to which the 
organism was susceptible. Contamination was de-
fined as one positive culture without elevated CRP 
or antibiotic therapy. Cases with definite or possible 
CONS sepsis were included in our analysis.
3.  Results
3.1.  Incidence
Between January 1, 2001 and December 31, 2006, 
2727 neonates were admitted to the NICU. Of these, 
100 neonates with 109 episodes of sepsis were in-
cluded in this study. The incidence of sepsis was 
4.00% among all NICU infants, or 2.70 per 1000 
patient-days. There were 28 episodes in 28 infants 
of early-onset sepsis and 81 episodes in 72 infants 
of late-onset sepsis. Of these, two (7%) episodes of 
early-onset sepsis and 64 (79%) episodes of late-
onset sepsis occurred in VLBW infants (p < 0.05). 
The gender, gestational age, birth weight and mode 
of delivery of these patients are shown in Table 1. 
The late-onset sepsis rates and patient-day rates 
stratified by birth weight group are shown in Table 2.
Ninety-three (93%) infants had a single episode 
of sepsis. Five (5%) infants had two episodes and 
two infants had three episodes of sepsis; all but 
one of these infants were of VLBW. The causative 
pathogens are shown in Table 3. The mean age of 
onset of lateonset sepsis was 25.3 days of age (range: 
7−95 days).
3.2.  Distribution of pathogens
In infants with early-onset sepsis, group B strepto-
cocci (GBS) (36%) was the major causative patho-
gen, followed by Escherichia coli (E. coli) (26%) and 
CONS (13%). On the other hand, the most common 
microorganism in late-onset sepsis was CONS (40%), 
followed by Candida (15.4%) and Staphylococcus 
aureus (SA) (13%). Overall, gram-positive microor-
ganisms accounted for 65% of cases of neonatal sep-
sis, followed by gram-negative microorganisms and 
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Candida (25% and 11%, respectively). Five episodes 
of sepsis were due to polymicrobial infection.
3.3.  Mortality and morbidity
In total, 20 (20%) of the 100 infants died. Nine in-
fants (8%) died within 7 days of septic episodes. 
Six (21%) of these infants were in the early-onset 
sepsis group and 14 (19%) were in the late-onset sep-
sis group. Three (10%) infants with early onset sep-
sis and six (7%) infants with late-onset sepsis died 
within 7 days after the onset of sepsis, and their 
deaths were considered sepsis-related. In those with 
early-onset sepsis, the sepsis-related mortality rates 
were 25% for E. coli infection, but zero for GBS 
and Methicillin-resistance coagulase-negative sta-
phylococci (MRCONS) infection. The mortality rates 
for the major pathogens in patients with late-onset 
sepsis were 22% (2/9), 3% (1/34) and 11% (1/9) 
for Candida parapsilosis, MRCONS and Methicillin-
resistance Staphylococci aureus (MRSA), respectively. 
Overall, the highest sepsis-related fatality rate was 
Table 1  Gender, gestational age, birth weight and mode of delivery of infants with early-onset and late-onset 
neonatal sepsis
 Early-onset n (%) Late-onset n (%) Total n (%) p-value
Episodes of sepsis 28 81 109
Number of infants 28 72 100
Inborn:Outborn 7:21 9:63 16:84
Gender
 Males:Females 2.1:1 1.3:1 1.5:1
 Male 19 (67.9) 46 (56.8) 65
 Female 9 (32.1) 35 (43.2) 44
Gestational age
 Median (range) 38 (23−40) 28 (22−40) 29 (22−40) < 0.05
 < 28 wk 1 (3.5) 38 (46.9) 39 (35.8)
 28−32 wk 1 (3.5) 30 (37.0) 31 (28.4)
 33−36 wk 4 (14.3) 1 (1.2) 5 (4.6)
 > 36 wk 22 (78.6) 12 (14.8) 34 (31.2)
Birth weight
 Median (range) 2780 (636−4130) 1050 (522−3500) 1172 (522−4130) < 0.05
 ≤ 1000 g 1 (3.5) 37 (45.7) 38 (34.8)
 1001−1500 g 1 (3.5) 27 (33.3) 28 (25.6)
 1501−2000 g 3 (10.7) 6 (7.4) 9 (8.3)
 2001−2500 g 4 (14.3) 1 (1.2) 5 (4.6)
 > 2500 g 19 (67.9) 10 (12.3) 29 (26.6)
Mode of delivery
 Vaginal delivery:Cesarean section 1.7:1 0.5:1 0.8:1 < 0.05
 Vaginal delivery 18 (64.3) 30 (37.0) 48 (44.0)
 Cesarean section 10 (35.7) 51 (63.0) 61 (56.0)










 Admissions (n) 
patient-days
 patient  rate (per 1000 RR
    rate (%) patient-days)
≤ 1000 37 273 12,128 13.6 3.0 3.33
1001−1500 27 317 10,523 8.5 2.6 2.89
1501−2000 6 399 5994 1.5 1.0 1.11
> 2000 11 1738 11,732 0.6 0.9 1
RR = relative risk.
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15% for Candida infection, followed by 8% and 7% for 
gram-positive and gram-negative microorganisms, 
respectively.
CSF studies were performed in 96% (27/28) of 
episodes of early-onset sepsis and 47% (38/81) of 
episodes of late-onset sepsis. The meningitis rates, 
defined by positive CSF culture, were 26% (7/27) and 
5% (2/38) for early- and late-onset sepsis, respec-
tively. Of the early-onset sepsis path ogens, GBS (36%) 
had a higher meningitis rate than E. coli (25%).
3.4.  Sensitivity to antibiotics
There were nine episodes of E. coli sepsis, of which 
eight were early-onset and one was late-onset sep-
sis. Five of the nine isolates (55%) were resistant 
to ampicillin, and three (33%) were resistant to gen-
tamicin. Extended-spectrum β-lactamases (ESBL) 
strain E. coli was present in one infant, who died at 
3 days of age due to necrotizing enterocolitis with 
bowel perforation. Seventy-eight percent (7/9) of 
S. aureus isolates were methicillin-resistant. All CONS 
isolates were methicillin-resistant. 
3.5.  Hematological parameters
White blood cell (WBC) counts and differential counts 
drawn on the first day of sepsis were available for 
108 and 92 episodes, respectively. The mean WBC 
was 10,784/mm3 (range: 1160−87,310/mm3). Leuco-
penia (WBC < 5000/mm3) and neutropenia (absolute 
neutrophil count: < 2750/mm3) were observed in 27% 
(29/108) and 34% (31/92) of episodes, respectively. 
An I/T (immature form of neutrophil/total neutro-
phil count) ratio greater than 0.2 was observed in 
27% (25/92) of events. Only 5% (6/108) of episodes 
Table 3 Pathogens isolated from patients with early-onset and late-onset neonatal sepsis
Pathogens
 Early-onset Late-onset Total
 Episodes  Attributable  Episodes Attributable Episodes  Attributable
 n (%) mortality* n (%) mortality*  n (%) mortality*
Gram-positive
 MRCONS 4 (13%) 0 34 (40%) 1 (3%) 38 1 (2.6%)
 GBS 11 (36%) 0 1 (1%) 0 12 0
 MRSA   9 (11%) 1 (11%) 9 1 (11%)
 MSSA   2 (2%) 0 2 0
 Enterococcus faecalis 1 (3%) 0 5 (6%) 0 6 0
 Enterococcus faecium   2 (2%) 0 2 0
 Streptococcus bovis II   1 (1%) 0 1 0
 Streptococcus pneumoniae   1 (1%) 1 (100%) 1 1 (100%)
 Listeria monocytogenes 1 (3%) 0   1 0
 Clostridium tertium 1 (3%) 1 (100%)   1 1 (100%)
Gram-negative
 E. coli 8 (26%) 2 (25%) 1 (1%) 0 9 2 (22%)
 Klebsiella pneumoniae 1 (3%) 1 (100%) 6 (7%) 0 7 1 (14%)
 Enterobacter cloacae 1 (3%) 0 3 (4%) 0 4 0
 Pseudomonas aeruginosa 1 (3%) 0 3 (4%) 0 4 0
 Stenotrophomonas    1 (1%) 1 (100%) 1 1 (100%)
  maltophilia
 Acinetobacter baumannii   1 (1%) 0 1 0
 Enterobacter aerogenes   1 (1%) 0 1 0
 Bacillus species 1 (3%) 0   1 0
Fungi
 Candida parapsilosis   9 (11%) 2 (22%) 9 2 (22%)
 Candida albicans   3 (3%) 0 3 0
 Candida species   1 (1%) 0 1 0
Total 30 3/28 (10.7%)† 84 6/81 (7.4%)‡ 104 9/109 (8.2%)
*Attributable mortality: neonate died within 7 days of sepsis onset; †3 infants died within 28 sepsis episodes, 2 polymicrobial 
infections; ‡6 infants died within 81 sepsis episodes, 3 polymicrobial infections; GBS = group B streptococci; MRCONS = methicillin-
resistance coagulase-negative staphylococci; MRSA = methicillin-resistance Staphylococci aureus; MSSA = methicillin-sensitive 
Staphylococci aureus.
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were accompa nied by leukocytosis (WBC > 25,000/
mm3). CRP levels drawn on the first day of sepsis 
were elevated in 58% (56/97) of events. On the 
second day of sepsis, elevated CRP levels were 
recorded in 11 out of 12 infants.
3.6.  Clinical symptoms and signs
Respiratory distress (60%), cyanosis (39%), fever (36%) 
and poor activity (36%) were the most common clin-
ical presentations in early-onset sepsis. In contrast, 
desaturation (70%), bradycardia (48%), apnea (47%) 
and poor activity (43%) were most common in late-
onset sepsis. 
3.7.  Therapeutic interventions
Of all episodes of late-onset sepsis, central line in-
sertion was reported in 40 of 81 (49%) episodes dur-
ing sepsis onset. The mean duration from central 
line insertion to onset of sepsis was 14 days. Catheter-
related sepsis was observed in 20 cases. The leading 
causative pathogen was Candida (8/20), followed 
by CONS (5/20) and MRSA (2/20). Endotracheal 
tube place ment with a mechanical ventilator was 
recorded in 16 infants with late-onset sepsis dur-
ing in fection (19%). The mean duration between 
endotracheal tube insertion to onset of sepsis was 
19 days (range: 2−77 days). 
4.  Discussion
The incidence rate of sepsis in our study was 4.00% 
among all NICU admissions, and the nosocomial in-
fection rate was 3.2%. A study by Jiang et al, also con-
ducted in Taiwan, showed a 3.01% neonatal sepsis 
rate among all admissions and a 2.7% nosocomial 
sepsis rate.3 Another prospective study in Taiwan 
revealed a 4.7% nosocomial sepsis rate.6 The ma-
jority of infants (79%) suffering from late-onset 
sepsis were of VLBW. The relative risk for late-onset 
sepsis was higher in the lower birth weight groups. 
In contrast, VLBW infants accounted for only 7% of 
cases of early-onset sepsis. The premature and VLBW 
babies were at increased risk of nosocomial infection 
because of more aggressive and invasive therapies, 
such as indwelling central lines, mechanical ventila-
tion, parenteral hyperalimentation and longer hos-
pital stay.2,7 
The pathogens responsible for neonatal sepsis 
in Taiwan appear to have changed over time (Tables 
3 and 4). In our study, GBS was found to be the 
most common causative pathogen (36%) in early-
onset sepsis in our study. In contrast, GBS was re-
sponsible for 6% of cases of early-onset sepsis in 
the reports by Wei et al (1981−1983), and increased 
to 18.1% the study by Jiang et al (1992−2001) and 
28.6% the study by Lee et al (1999−2001).3,8,9 In 
contrast, S. aureus accounted for 3.6−14% of cases 
of early-onset sepsis in previous studies but was 
not found in our study.3,9,10 The proportion cases of 
early-onset sepsis caused by E. coli has remained 
steady, accounting for 26% of cases in our study, 
which is comparable with the other reports from 
Taiwan.3,9 Fungal infection is a increasing problem 
in late-onset sepsis and nosocomial infection. We 
found that 15% of the pathogens causing late-onset 
sepsis were Candida, a proportion much higher than 
that previously recorded.3,10,11
GBS and E. coli were the most commonly observed 
pathogens in early-onset sepsis, as in other coun-
tries.1,3,5,12,13 After implementation of intrapartum 
antibiotic prophylaxis (IAP) guidelines, the rate of 
early-onset GBS infection declined by 70% in the 
United States. E. coli has also replaced GBS as the 
leading cause of early-onset sepsis in VLBW.5 In 
Taiwan, the GBS colonization rate in third-trimester 
pregnant women was 11.1−15%.14,15 However, screen-
ing is not performed universally. This may explain 
the high proportion of GBS infection observed in 
our study. GBS screening and IAP guidelines should 
be popularized in Taiwan to prevent neonatal early-
onset sepsis.
The increased incidence of E. coli sepsis in early-
onset sepsis has recently become a problem in the 
United States.5 Gram-negative sepsis is particularly 
lethal. The increasing resistance of E. coli isolates to 
ampicillin may be due to maternal intrapartum am-
picillin prophylaxis.5,16,17 Ampicillin- and gentamicin-
resistant E. coli were isolated in 55% and 33%, 
respectively, of neonates in our study. Ampicillin 
and gentamicin are widely used as initial therapy 
for suspected early-onset sepsis in our practice. 
Cefotaxmin should replace gentamicin in such in-
fants to treat possible resistant strains. The over-
all ampicillin-resistance of E. coli was 79% in our 
hospital in 2006. 
CONS was the most common pathogen that caused 
neonatal late-onset sepsis in our study, as in previ-
ous reports.2,3,6,7 The main problem was distinguish-
ing true blood infections from contaminations. The 
sepsis-related mortality was 3% in our study, which 
is compatible with other reports.2,18,19 The wide-
spread use of vancomycin in NICUs may result in 
vancomycin-resistant strains of pathogens such as 
enterococci. A multicenter survey of neonatolo-
gists’ practices in the treatment of neonates with 
suspected late-onset sepsis found that, in 83% of 
centers surveyed, at least 75% of survey respon-
dents had similar practices with regard to prescrib-
ing a vancomycin-containing regimen for empiric 
therapy.20 Karlowicz reported that substitution of 
oxacillin for vancomycin as the empiric antibiotic 
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for suspected gram-positive sepsis had no effect 
on the frequency of fulminate sepsis for CONS.19 In 
our practice, the empiric antibiotics are ampicillin 
or oxacillin for suspected late-onset sepsis, and 
vancomycin is used in toxic infants. Twenty-one 
(61%) infants who had CONS late-onset sepsis did 
not receive vancomycin therapy as empiric antibi-
otics before their blood culture report. However, 
all CONS in our study were methicillin-resistant 
strains, and all infected infants ultimately received 
vancomycin therapy. 
In late-onset sepsis, Candida species accounted 
for the second greatest number of cases. The most 
pre valent pathogens were Candida albicans and 
C. parapsilosis. C. albicans has been previously re-
ported as the leading cause of neonatal sepsis.2,21,22 
However, C. parapsilosis was the most common 
species in our study. In recent reports, C. parapsi-
losis was the predominant fungal infection in some 
NICUs.23 Evidence suggests that the growth and 
adherence of C. parapsilosis is enhanced in high 
glucose and certain hyperalimentation solutions.24 
The central venous catheter insertion site is re-
ported to provide a portal of entry for fungi. An as-
sociation between the insertion of a central venous 
catheter with C. parapsilosis sepsis has been 
reported.25,26 Indwelling central venous catheters 
and hyperalimentation solution are both essential 
Table 4 Neonatal sepsis analyses in Taiwan
 Ku-Nein Jia-Horng Ya-Chun Sung-His Ni-Chung
 Wei9 Jiang3 Tseng11 Wei10 Lee8
Years 1981−1983 1992−2001 1997−1999 1997−2003 1999−2001
Case numbers 160 270  208 58
Episodes 165 325 137 232 85
Population Early and late Early and late Nosocomial Nosocomial Early and
 onset onset   late onset
Hospital Mackay Mackay China  China Taipei
 Memorial Memorial Medical Medical Veterans 
 Hospital Hospital University University General
   Hospital Hospital Hospital
 Early Late  Early  Late  Nosocomial Nosocomial Early  Late 
 onset onset onset onset   onset onset
Gram-positive
 GBS 3 (6) 1 (0.9) 15 (18.1) 3 (1.1)   2 (28.6)
 SA 7 (14) 17 (14.8) 3 (3.6) 41 (15.2) 25 (18.5) 46 (18.0) 1 (14.3) 18 (22.5)
 CONS 2 (4) 4 (3.5) 11 (13.2) 60 (22.2) 3 (2.2) 5 (2.0) 2 (28.6) 23 (28.8)
 Enterococcus     6 (4.4) 12 (4.7)  2 (2.5)
 Others 4 (8) 7 (6.0) 12 (14.5) 15 (5.6)  8 (3.1)
Gram-negative
 E. coli 10 (20) 22 (19.1) 18 (21.7) 26 (9.6) 13 (9.6) 17 (6.6)
 Klebsiella 4 (8) 14 (12.2) 3 (3.6) 22 (8.2) 16 (11.9) 20 (7.8) 2 (28.6) 8 (10)
  pneumoniae
 Enterobacter 3 (6) 5 (4.3)   11 (8.1) 12 (4.7)  18 (22.5)
 Pseudomonas 11 (22) 15 (13.0) 5 (6.0) 15 (5.6) 11 (8.1) 21 (8.2)
  aeruginosa
 Stenotrophomonas     6 (4.4) 7 (2.7)
  maltophilia
 Acinetobacter  1 (2) 6 (5.2)  26 (9.6) 22 (16.3) 39 (15.2)  4 (5)
  baumannii
 Others 5 (10) 24 (20.7) 16 (19.3) 45 (16.7) 11 (8.1) 40 (15.6)  1 (1.2)
Fungi − −      6 (7.5)
 Candida albicans    9 (3.3) 8 (5.9) 19 (7.4)
 Candida    3 (1.1)
  guilliermondi
 Others    5 (1.9)  10 (3.9)
CONS = coagulase-negative staphylococci; GBS = group B streptococci; SA = Staphylococci aureus.
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treatments for VLBW infants; therefore, it is unsur-
prising that C. parapsilosis is becoming an increas-
ingly common pathogen in these infants. Hospital 
personnel frequently carry Candida species on their 
hands, with C. parapsilosis being the most common 
species identified.27,28 Restrictive hand-washing pro-
cedures in the NICU might lower horizontal transmis-
sion of C. parapsilosis and prevent Candida sepsis. 
Early diagnosis of neonatal sepsis is important, but 
clinical signs are neither specific nor uniform. Many 
markers have been developed for early detection, 
including cell-surface markers (CD11b, CD64 and 
CD69), chemokines and cytokines (IL-6, IL-8, IL-10) 
and acute phase reactants (CRP, procalcitonin, serum 
amyloid A and inter-alpha inhibitor protein).29,30 
How ever, no single infection marker is sensitive and 
specific enough to convince a doctor to withdraw 
antibiotics therapy in a sick infant. Developing di-
agnostic tools such as DNA arrays may be useful in 
the future.31,32
The limitations of our study are its restriction to 
a single medical center, retrospective review met-
hod and exclusion of infants who were admitted to 
the cardiovascular surgery intensive care unit. 
5.  Conclusions
In conclusion, the majority of infants with early-
onset sepsis were term babies. In contrast, late-
onset sepsis affected mainly preterm and VLBW 
babies. Unlike previous reports from Taiwan, GBS 
was the most common pathogen responsible for 
early-onset sepsis. GBS screening and IAP guide-
lines should be popularized in Taiwan to prevent 
neonatal early-onset sepsis. The leading causative 
microorganisms in late-onset sepsis were CONS and 
Candida species. C. parapsilosis was associated with 
a high mortality rate.
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